The reverse split is a compliance-driven action with no fundamental change to the business. Monitor the stock's post-split trading price and any subsequent NYSE American listing determination — the company's explicit disclaimer of assurance suggests ongoing listing risk.
Price Chart
Executive Summary
Matinas BioPharma announced a 1-for-15 reverse stock split, effective September 28, 2026, to regain compliance with NYSE American listing standards. The split is a mechanical capital structure adjustment with no change to proportional ownership or par value, but the company explicitly cautions there is no assurance it will maintain its listing.
Key Facts
- Reverse stock split ratio: 1-for-15, effective 12:01 a.m. ET on September 28, 2026
- Trading symbol MTNB unchanged; new CUSIP: 576810 402
- No fractional shares issued; cash paid in lieu of fractional shares
- Authorized shares and par value ($0.0001) unchanged
- Company states no assurance the split will enable continued NYSE American listing
Financial Impact
No direct financial impact disclosed; proportional ownership unchanged. Cash payments for fractional shares will be immaterial.
Risk Factors
- NYSE American may still delist the stock if post-split price does not sustain compliance
- Reverse splits often carry negative signaling for micro-cap biotechs, potentially pressuring the stock
- Fractional share cash payments create minor administrative friction for small holders
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-042954 |
| Document: 0001493152-26-042954-index-headers.html | 0001493152-26-042954 |
| Document: 0001493152-26-042954-index.html | 0001493152-26-042954 |
| Document: 0001493152-26-042954.txt | 0001493152-26-042954 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 29d ago | 8-K | $2.53 $1.66 | ▼ −34.39% | ▼ −34.36% | $1.83 (−27.67%) |
Sep 16, 2026 5w ago | 8-K | $0.1630 $0.1613 | ▼ −1.02% | ▼ −2.23% | $1.83 (+1022.70%) |
Sep 4, 2026 7w ago | 8-K | $0.1820 $3.01 | ▼ −1553.85% | ▼ −1552.13% | $1.83 (−905.49%) |
Aug 25, 2026 9w ago | 425 | $0.1973 $0.1750 | ▲ +11.30% | ▲ +12.28% | $1.83 (−827.52%) |
Jul 30, 2026 12w ago | 425 | $0.3174 $0.2000 | ▲ +36.99% | ▲ +40.95% | $1.83 (−476.56%) |
Jul 24, 2026 13w ago | 8-K | $0.3320 $0.1965 | ▲ +40.81% | ▲ +44.11% | $1.83 (−451.20%) |
Jul 13, 2026 15w ago | 425 | $0.4800 $0.2690 | ▲ +43.96% | ▲ +47.14% | $1.83 (−281.25%) |
Jul 13, 2026 15w ago | 8-K | $0.4800 $0.2690 | ▲ +43.96% | ▲ +47.14% | $1.83 (−281.25%) |
Jun 26, 2026 17w ago | 8-K | $0.6640 $0.2414 | ▲ +63.64% | ▲ +63.37% | $1.83 (−175.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers